Literature DB >> 28766827

Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?

R Rajasingham1, D B Meya1,2, D R Boulware1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28766827      PMCID： PMC5794638          DOI： 10.1111/hiv.12543

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  4 in total

1.  The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.

Authors:  Bing Zhai; Cheng Wu; Linqi Wang; Matthew S Sachs; Xiaorong Lin
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.

Authors:  Duangchit Panomvana Na Ayudhya; Nawarat Thanompuangseree; Somsit Tansuphaswadikul
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.

Authors:  Elissa K Butler; David R Boulware; Paul R Bohjanen; David B Meya
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

4.  Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Authors:  Joshua Rhein; Bozena M Morawski; Kathy Huppler Hullsiek; Henry W Nabeta; Reuben Kiggundu; Lillian Tugume; Abdu Musubire; Andrew Akampurira; Kyle D Smith; Ali Alhadab; Darlisha A Williams; Mahsa Abassi; Nathan C Bahr; Sruti S Velamakanni; James Fisher; Kirsten Nielsen; David B Meya; David R Boulware
Journal:  Lancet Infect Dis       Date:  2016-03-10       Impact factor: 25.071
  4 in total
  2 in total

1.  Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.

Authors:  Supavit Chesdachai; Radha Rajasingham; Melanie R Nicol; David B Meya; Felix Bongomin; Mahsa Abassi; Caleb Skipper; Richard Kwizera; Joshua Rhein; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

Review 2.  Tuberculosis and pharmacological interactions: A narrative review.

Authors:  Niccolò Riccardi; Diana Canetti; Paola Rodari; Giorgio Besozzi; Laura Saderi; Marco Dettori; Luigi R Codecasa; Giovanni Sotgiu
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.